WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 2, 2005, 25(44):10220-10229; doi:10.1523/JNEUROSCI.2773-05.2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perez, S. E.
Right arrow Articles by Mufson, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perez, S. E.
Right arrow Articles by Mufson, E. J.

 Previous Article  |  Next Article 

Neurobiology of Disease
Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1{Delta}E9 Transgenic Mice

Sylvia E. Perez,1 Orly Lazarov,2 James B. Koprich,1 Er-Yun Chen,1 Virginia Rodriguez-Menendez,3 Jack W. Lipton,1 Sangram S. Sisodia,2 and Elliott J. Mufson1

1Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, 2Department of Neurobiology, Pharmacology, and Physiology, University of Chicago, Chicago, Illinois 60637, and 3Department of Neuroscience and Biomedical Technologies, University of Milano-Bicocca, 20052 Monza (MI), Italy

Alzheimer's disease (AD) is often accompanied by extrapyramidal signs attributed to nigrostriatal dysfunction. The association between amyloid deposition and nigrostriatal degeneration is essentially unknown. We showed previously that the striatum and the substantia nigra of transgenic mice harboring familial AD (FAD)-linked APPswe/PS1{Delta}E9 mutants exhibit morphological alterations accompanied by amyloid-{beta} (A{beta}) deposition (Perez et al., 2004). In the present study, we further investigated the interaction between A{beta} deposition and dopaminergic nigrostriatal dysfunction, by correlating morphological and biochemical changes in the nigrostriatal pathway with amyloid deposition pathology in the brains of 3- to 17-month-old APPswe/PS1{Delta}E9 transgenic mice and age-matched wild-type controls. We show that A{beta} deposition is pronounced in the striatum of APPswe/PS1{Delta}E9 mice at 6 months of age, and the extent of deposition increases in an age-dependent manner. Tyrosine hydroxylase (TH)-positive dystrophic neurites with rosette or grape-like cluster disposition are observed adjacent to A{beta} plaques and display multilaminar, multivesicular, and dense-core bodies as well as mitochondria. In addition, an age-dependent increase of TH protein levels are shown in nigral cells in these mutant mice. Using HPLC analysis, we found a reduction in the dopamine metabolite DOPAC in the striatum of these mice. These findings show a close association between amyloid deposition and nigrostriatal pathology and suggest that altered FAD-linked amyloid metabolism impairs, at least in part, the function of dopaminergic neurons.

Key words: Alzheimer's disease; amyloid; nigrostriatal; transgenics; dopamine; parkinsonism


Received July 5, 2005; revised September 23, 2005; accepted September 27, 2005.




This article has been cited by other articles:


Home page
IOVSHome page
S. E. Perez, S. Lumayag, B. Kovacs, E. J. Mufson, and S. Xu
{beta}-Amyloid Deposition and Functional Impairment in the Retina of the APPswe/PS1{Delta}E9 Transgenic Mouse Model of Alzheimer's Disease
Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 793 - 800.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Liu, M.-J. Yoo, A. Savonenko, W. Stirling, D. L. Price, D. R. Borchelt, L. Mamounas, W. E. Lyons, M. E. Blue, and M. K. Lee
Amyloid Pathology Is Associated with Progressive Monoaminergic Neurodegeneration in a Transgenic Mouse Model of Alzheimer's Disease
J. Neurosci., December 17, 2008; 28(51): 13805 - 13814.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W. E. Klunk, J. C. Price, C. A. Mathis, N. D. Tsopelas, B. J. Lopresti, S. K. Ziolko, W. Bi, J. A. Hoge, A. D. Cohen, M. D. Ikonomovic, et al.
Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees
J. Neurosci., June 6, 2007; 27(23): 6174 - 6184.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2010 by Society for Neuroscience ONLINE ISSN: 1529-2401
-